We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

COVID-19 – Accelerating Vaccine Development and Manufacturing

Article

Technology Networks spoke with Dr Paul Hodgson, Associate Director of Business Development at VIDO-InterVac to learn more about their experience working with coronaviruses, the organization's manufacturing facilities, and the other antivirals and therapeutics they are currently testing in relation to COVID-19.

Read more

Testimonial: Use of Rotavapors for Drug Discovery and Formulation in Academic Research

Video

Dr. Fabiana Quaglia, Associate Professor of Pharmaceutical Technology at the Faculty of Pharmacy–University of Napoli Federico II, Italy discusses how reliability and smart features of the rotary evaporator, Rotavapor® R-300, let her easily evaporate solvents in particle production for cancer and cystic fibrosis drug development and formulation.

Watch Now

Exploring Chromatographic Techniques

List

Download this list to discover more about some of the key chromatographic techniques, exploring how they work, their applications and their limitations.

Read more

Anti-parasitic Drug Eliminates SARS-CoV-2 Within 48 Hours in Cell Culture

News

A Monash University-led study has shown that an anti-parasitic drug already available around the world can kill the virus within 48 hours in cell culture.

Read more
 
Treating COVID-19 in a Patient With Multiple Myeloma – A Case Study
News

A case study of a patient in Wuhan, China, suggests that the immunosuppressant tocilizumab may be an effective therapeutic strategy against COVID-19 in infected patients who also have multiple myeloma and other blood cancers.

Read more

Sea Sponge Molecule May Stop Cervical Cancer Cell Growth
News

A sponge found in Manado Bay, Indonesia, synthesizes a molecule called manzamine A, which has been shown to stop the growth of cervical cancer cells. The study explored the anti-growth and cancer cell-killing effects of manzamine A in different cervical cancer cell lines.

Read more

Clues to SARS-CoV-2 Vulnerability Emerge
News

An antibody recovered from a survivor of the SARS epidemic in the early 2000s has revealed a potential vulnerability of the new coronavirus at the root of COVID-19, according to a study from scientists at Scripps Research.

Read more

 
 
 
Advertisement
 

COVID-19: Screening Antiviral Drugs Using SARS-CoV-2 Infection Models

Article

Researchers from Queen’s University Belfast will screen approximately 1,000 drugs, which have already received regulatory approval for other indications, to ascertain if they can reduce virus infection or replication and virus-induced inflammatory responses in airway epithelial cell models and to determine if they can therefore be repurposed to treat COVID-19 patients.

Read more
 
Pitfalls and Promises in Early Phase Oncology Trials
Article

Better cumulative decisions in early phases of drug development could lead to a greater chance of clinical success, as the correct dosage can be identified and tested in the right patient populations for the right early indicator. In this article, we delve into the current and future aspects of early-phase oncology trials.

Read more

The Coronavirus Outbreak
Article

On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to the outbreak.

Read more

Keep Up to Date With COVID-19 Vaccine Development
Article

Technology Networks is committed to keeping you updated with the latest research in this space. Below, you'll find a curation of our latest COVID-19 vaccine-related content.

Read more

 
 
 
Advertisement